Published DateClear

Start Date

End Date

Category

• Pipeline2
• Business1

Organizations

• Bausch + Lomb67
• Eyes On Eyecare53
• Alcon, Inc.47
• American Optometric Association38
• Harrow31
• Glaukos28
• Regeneron25
• Topcon Healthcare25
• Aldeyra Therapeutics21
• Sight Sciences19

Tags

• Clinical Trials3
• Glaucoma3
• Medical Device3
• Aaophthalmology1
• FDA1
• IOP1
• Finances1
• Glaucoma Management1
• Glaucoma Surgery1
• Research1

• Organizations: Avisi Technologies✕

Clear all

Business

Avisi raises $10.7M to advance study on VisiPlate glaucoma device

Financing to support IDE-approved study evaluating the novel minimally-invasive bleb surgery shunt for lowering IOP via aqueous drainage control. 

Pipeline

FDA grants IDE approval for Avisi's glaucoma treatment device

IDE approval enables initiation of the open-label SAPPHIRE to evaluate the VisiPlate, an aqueous shunt designed to lower IOP among OAG patients.

Pipeline

Avisi reports positive 6-month data on VisiPlate aqueous shunt for glaucoma

MIBS device composed of non-fibrotic nanotechnology-based metamaterials lowered OAG patients’ mean IOP by 40%.